Literature DB >> 15115145

Comparative study of anti-double stranded DNA detection by ELISA and Crithidia luciliae immunofluorescence.

Kritsana Janyapoon1, Pantakit Jivakanont, Kantima Choosang, Rungkarn Surbrsing, Vannapa Charoenying, Sirinya Baithong.   

Abstract

Two commercial enzyme-linked immunosorbent assays (ELISA) and two commercial Crithidia luciliae immunofluorescence tests (CLIF) were reevaluated as to the efficiency and degree of correlation of anti-double stranded DNA (anti-dsDNA) detection in systemic lupus erythematosus (SLE). The two ELISAs exhibited an overall agreement of 95% and significantly correlated with each other (r=0.91, p<0.001). They were comparable in sensitivity (64%, 61%) and had the same specificity (95%, 95%). The sensitivity of the two CLIFs was 39% and 29% with corresponding specificities of 100% and 97%, and an overall agreement with each other of 94%. The two ELISAs had comparable specificity to the CLIFs with good agreement (84%, 79%) while they had a much greater sensitivity than the CLIFs. These findings suggest that ELISA is a useful laboratory test for anti-dsDNA detection of SLE due to its simplicity, quantitative results, sensitivity, specificity and cost, as compared to CLIFs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15115145

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Generalised lymphadenopathy as the first manifestation of lupus nephritis.

Authors:  Hassan Al-Hashimi; Angshu Bhowmik
Journal:  BMJ Case Rep       Date:  2010-04-22

2.  Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings.

Authors:  Brahim Admou; Fatima-Ezzohra Eddehbi; Lahcen Elmoumou; Saad Elmojadili; Abdelmouïne Salami; Mohammed Oujidi; Imane Brahim; Raja Hazime
Journal:  Pract Lab Med       Date:  2022-06-03

3.  Quantitative Mass Spectrometric Analysis of Autoantibodies as a Paradigm Shift in Autoimmune Serology.

Authors:  Adrian Y S Lee; Tim Chataway; Alex D Colella; Tom P Gordon; Jing J Wang
Journal:  Front Immunol       Date:  2019-12-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.